BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
合作关系 - BioRestorative Therapies与Galen Patient Recruitment合作，加速进行中的BRTX-100慢性腰椎间盘疾病（cLDD）第二阶段研究的患者招募[1] 治疗药物介绍 - BRTX-100是一种新型的基于细胞的治疗药物，旨在针对体内血流较少的区域[2] Galen Patient Recruitment - Galen Patient Recruitment自2006年以来通过成本效益的患者招募解决方案帮助客户推出新的医疗创新[4]